assembly Bill A3573A

2017-2018 Legislative Session

Relates to the possession of opioid antagonists

download bill text pdf

Sponsored By

Archive: Last Bill Status - Passed Assembly


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (13)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 04, 2018 referred to rules
delivered to senate
passed assembly
May 14, 2018 amended on third reading 3573a
Jan 03, 2018 ordered to third reading cal.278
returned to assembly
died in senate
Mar 08, 2017 referred to codes
delivered to senate
passed assembly
Mar 02, 2017 advanced to third reading cal.106
Mar 01, 2017 reported
Jan 27, 2017 referred to codes

A3573 - Details

Current Committee:
Senate Rules
Law Section:
Criminal Procedure Law
Laws Affected:
Add §60.49, CP L; add §4519-a, CPLR; amd §841, add §214-g, Exec L
Versions Introduced in Other Legislative Sessions:
2013-2014: A10015
2015-2016: A2962
2019-2020: A746
2021-2022: A2354

A3573 - Summary

Relates to the possession of opioid antagonists and receipt into evidence.

A3573 - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  3573

                       2017-2018 Regular Sessions

                          I N  A S S E M B L Y

                            January 27, 2017
                               ___________

Introduced  by  M. of A. LENTOL, HARRIS -- read once and referred to the
  Committee on Codes

AN ACT to amend the criminal procedure law, the civil practice  law  and
  rules  and  the executive law, in relation to the possession of opioid
  antagonists

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Section 60.48 of the criminal procedure law is renumbered
section 60.49 and a new section 60.48 is added to read as follows:
§ 60.48 POSSESSION OF OPIOID ANTAGONISTS; RECEIPT INTO EVIDENCE.
  1. EVIDENCE THAT A PERSON WAS IN POSSESSION OF  AN  OPIOID  ANTAGONIST
MAY NOT BE ADMITTED AT ANY TRIAL, HEARING OR OTHER PROCEEDING IN A PROS-
ECUTION  FOR  ANY OFFENSE UNDER SECTIONS 220.03, 220.06, 220.09, 220.16,
220.18, OR 220.21 OF THE PENAL LAW FOR THE PURPOSE OF ESTABLISHING PROB-
ABLE CAUSE FOR AN ARREST OR PROVING  ANY  PERSON'S  COMMISSION  OF  SUCH
OFFENSE.
  2. FOR THE PURPOSES OF THIS SECTION, OPIOID ANTAGONIST IS DEFINED AS A
DRUG  APPROVED  BY  THE FOOD AND DRUG ADMINISTRATION THAT, WHEN ADMINIS-
TERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN  PART  THE  PHARMACOLOGICAL
EFFECTS  OF  AN  OPIOID IN THE BODY AND SHALL BE LIMITED TO NALOXONE AND
OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF HEALTH FOR SUCH PURPOSE.
  § 2. The civil practice law and rules  is  amended  by  adding  a  new
section 4519-a to read as follows:
  §  4519-A. POSSESSION OF OPIOID ANTAGONISTS; RECEIPT INTO EVIDENCE. 1.
POSSESSION OF AN OPIOID ANTAGONIST MAY NOT BE RECEIVED  IN  EVIDENCE  IN
ANY  TRIAL, HEARING OR PROCEEDING PURSUANT TO SUBDIVISION ONE OF SECTION
TWO HUNDRED THIRTY-ONE AND PARAGRAPH THREE OF SUBDIVISION B  OF  SECTION
TWO HUNDRED THIRTY-THREE OF THE REAL PROPERTY LAW OR SUBDIVISION FIVE OF
SECTION  SEVEN  HUNDRED  ELEVEN  AND  SUBDIVISION  ONE  OF SECTION SEVEN
HUNDRED FIFTEEN OF THE REAL PROPERTY  ACTIONS  AND  PROCEEDINGS  LAW  AS

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD03818-01-7

A3573A (ACTIVE) - Details

Current Committee:
Senate Rules
Law Section:
Criminal Procedure Law
Laws Affected:
Add §60.49, CP L; add §4519-a, CPLR; amd §841, add §214-g, Exec L
Versions Introduced in Other Legislative Sessions:
2013-2014: A10015
2015-2016: A2962
2019-2020: A746
2021-2022: A2354

A3573A (ACTIVE) - Summary

Relates to the possession of opioid antagonists and receipt into evidence.

A3573A (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 3573--A
                                                        Cal. No. 278

                       2017-2018 Regular Sessions

                          I N  A S S E M B L Y

                            January 27, 2017
                               ___________

Introduced by M. of A. LENTOL -- read once and referred to the Committee
  on Codes -- ordered to a third reading, amended and ordered reprinted,
  retaining its place on the order of third reading

AN  ACT  to amend the criminal procedure law, the civil practice law and
  rules and the executive law, in relation to the possession  of  opioid
  antagonists

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The criminal procedure law  is  amended  by  adding  a  new
section 60.49 to read as follows:
§ 60.49 POSSESSION OF OPIOID ANTAGONISTS; RECEIPT INTO EVIDENCE.
  1.  EVIDENCE  THAT  A PERSON WAS IN POSSESSION OF AN OPIOID ANTAGONIST
MAY NOT BE ADMITTED AT ANY TRIAL, HEARING OR OTHER PROCEEDING IN A PROS-
ECUTION FOR ANY OFFENSE UNDER SECTIONS 220.03, 220.06,  220.09,  220.16,
220.18, OR 220.21 OF THE PENAL LAW FOR THE PURPOSE OF ESTABLISHING PROB-
ABLE  CAUSE  FOR  AN  ARREST  OR PROVING ANY PERSON'S COMMISSION OF SUCH
OFFENSE.
  2. FOR THE PURPOSES OF THIS SECTION, OPIOID ANTAGONIST IS DEFINED AS A
DRUG APPROVED BY THE FOOD AND DRUG ADMINISTRATION  THAT,  WHEN  ADMINIS-
TERED,  NEGATES  OR  NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
EFFECTS OF AN OPIOID IN THE BODY AND SHALL BE LIMITED  TO  NALOXONE  AND
OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF HEALTH FOR SUCH PURPOSE.
  §  2.  The  civil  practice  law  and rules is amended by adding a new
section 4519-a to read as follows:
  § 4519-A. POSSESSION OF OPIOID ANTAGONISTS; RECEIPT INTO EVIDENCE.  1.
POSSESSION  OF  AN  OPIOID ANTAGONIST MAY NOT BE RECEIVED IN EVIDENCE IN
ANY TRIAL, HEARING OR PROCEEDING PURSUANT TO SUBDIVISION ONE OF  SECTION
TWO  HUNDRED  THIRTY-ONE AND PARAGRAPH THREE OF SUBDIVISION B OF SECTION
TWO HUNDRED THIRTY-THREE OF THE REAL PROPERTY LAW OR SUBDIVISION FIVE OF
SECTION SEVEN HUNDRED  ELEVEN  AND  SUBDIVISION  ONE  OF  SECTION  SEVEN
HUNDRED  FIFTEEN  OF  THE  REAL  PROPERTY ACTIONS AND PROCEEDINGS LAW AS

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets